πŸ‡ΊπŸ‡Έ FDA
Patent

US 8080236

Particulate materials

granted A61KA61K31/4985A61K47/06

Quick answer

US patent 8080236 (Particulate materials) held by Nektar Therapeutics UK, Ltd expires Mon Dec 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics UK, Ltd
Grant date
Tue Dec 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
112
CPC classes
A61K, A61K31/4985, A61K47/06, A61K47/08, A61K9/008